Likewise, the results of the analysis indicateed that a high level of SBF2-AS1 was linked to unfavorable clinical indices such as progressive TNM stages, distant metastasis and lymph node metastasis in certain cancers [27, 32, 35, 39, 44]. The gene discussed is SBF2; the disease is metastatic malignant neoplasm in the lymph nodes.